Real knowledge can be lost. Alzheimer's, dementia and the inevitable death. They aren't the only ones but they are heavy hitters against your statement. Anyway, that's not important!
You're howling at the moon. You want management to know you know. I get it.
I have done similar many times on MSB threads. It's healthy. Normal. Real. Correct.
Bravo!
How there isn't more of it is well beyond me.
The BoD and management here can not remain unchanged. This is a disaster. And the cash amount is so little. A$5M to contract out a P2 is NOT enough money.
Management have secured their wages for a while longer.
They've nominated their contractor to conduct the P2 FDA trial for GVHD - so why haven't they told the market how much has been quoted to deliver? How haven't they told shareholders? Don't they have a duty to disclose? Someone explain this to me? They've been planning for YEARS - they should know!!!
- Forums
- ASX - By Stock
- CYP
- Ann: Cynata Completes Oversubscribed Share Purchase Plan
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.0¢

Ann: Cynata Completes Oversubscribed Share Purchase Plan, page-16
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.15M |
Open | High | Low | Value | Volume |
16.0¢ | 16.5¢ | 16.0¢ | $62.06K | 386.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 70000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.160 |
3 | 48709 | 0.155 |
5 | 106673 | 0.150 |
2 | 45000 | 0.140 |
1 | 10937 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 70000 | 2 |
0.175 | 77450 | 2 |
0.180 | 146968 | 5 |
0.185 | 35990 | 1 |
0.195 | 19300 | 1 |
Last trade - 14.47pm 25/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online